PSCA and prostate cancer: Importantly, the treatment with genistein together with other two flavonoids belonging to the class of flavones (luteolin) and flavonols (quercetin) inhibited the expression of PSCA at the mRNA and protein level in prostate cancer DU145 cells [100].